APC 00894
Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
Telisotuzumab vedotin-tll
Lee's Summit, MO
See all hospitals reporting APC 00894 →Price type
Lee's Summit Medical Center’s median price of $146 is 2% above the median hospital's median price ($144), higher than 60% of the 131 hospitals reporting APC 00894. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Negotiated rates from the hospital’s own file: 1 payer, 1 plan rate. A facility fee, a professional fee, a per diem and a case rate are different bills, so each is listed on its own. Open a payer to see it across hospitals.
Filter by billing methodology
Filter by billing class
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | Blue Cross Blue Shield tricare fee schedule · outpatient | $146 | $146 | — | — | — | $146 – $146 |
Last updated: Mar 1, 2026
See Telisotuzumab vedotin-tll cancer drug infusion pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.